Vita 34 wins TOP 100 Innovation Award
Biotech company from Leipzig recognized as top innovator of small and medium-sized business in Germany
This year was the 23rd time that the TOP 100 the most innovative small and medium-sized businesses were recognized in Germany. Vita 34 AG is part of the innovative elite for the first time and received the Top Innovator Award from the hands of Ranga Yogeshwar, who mentors the innovation competition. Previously, the biotech company from Leipzig had successfully passed through a challenging scientific selection process to investigate the innovation management and success as well as other factors.
In this process, it became apparent that Vita 34 makes a considerable contribution to medical progress in the field of stem cell research with numerous research and development activities. The jury of the competition under the guidance of scientific director Prof. Dr. Nikolaus Franke (Institute of Entrepreneurship and Innovation, Vienna School of Economics) has honored the success and sustainability of the established innovation processes by calling Vita 34 a “long standing driver of innovation on the market of stem cell banks”.
The management is closely involved in the innovative processes and spends the better part of working time for them. CEO Dr. André Gerth says, “I like dealing with that subject so much, because innovations in all Vita 34 divisions are indispensable for further growth from a strategic point of view.” All innovation processes of Vita 34 are characterized by a particularly goal-oriented and detailed development. This is not the only reason why Vita 34 has a broad range of products and services, the constant enhancement of which is of tremendous importance. “We are determined to bring a new service, a new product, or a new production method onto the market every year”, says Dr. Gerth, “of course, to show that we won the TOP innovator award rightly – but mainly to further meet our customers’ expectations and needs in the future.”
Vita 34 stands out due to the multitude of external research activities. To examine the options of medical application of cord blood stem cells and to develop new cell products, the in-house scientists actively participate in the applied stem cell research and collaborate with numerous renowned research institutions and universities. Many years of experience and the acquired knowledge are expressed in the practical application, which is a benefit mostly for the customers of Vita 34. Because Vita 34 is the only private stem cell bank in Germany producing the actual medical application of the stem cell deposits previously stored for individual precaution and thus underlining the top quality of the stored stem cell preparations. High-quality processing and reliable long-term storage in compliance with the strictest quality and safety standards ensure the suitability of the stem cell deposits for therapeutic applications. To date, 30 of the stem cell deposits previously stored with Vita 34 have already been applied to patients suffering from blood diseases, infantile brain damage, neuroblastoma, or diabetes.
Especially in view of the great potential of stem cells in the regenerative medicine: Leading scientists assume that every seventh person may need a therapy based on stem cells during the course of their lives in the near future. The purpose of Vita 34 therefore is to provide access to new stem cell products and therapies to all people and to meet the market expectations and needs in the future as well by developing innovative products.
About TOP 100
Since 1993, compamedia awards the TOP 100 seal for special innovative force and above-average innovation success to small and medium-sized businesses. Since 2002, the responsible scientific director is Prof. Dr. Nikolaus Franke from the Institute of Entrepreneurship and Innovation of the Vienna School of Economics. Over 4,000 companies were interested in this year’s competition and evaluated in categories like “innovation-promoting management”, “innovation climate”, “innovative processes and organization”, “innovation marketing”, or ”innovation success”. The awarded companies belong to the pacemakers in their industries. The figures given in the evaluation prove it: Among the companies are 97 national market leaders and 32 leaders on the world market. The mentor of TOP 100, scientific journalist and TV host Ranga Yogeshwar, is impressed by the quality of the businesses and hopes for a signaling effect: “The way the TOP 100 generate new ideas and develop them into groundbreaking products and services, is remarkable in the truest sense of the word. That is why I am glad that the award makes these qualities visible.”